Correction to: SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast Cancer (Annals of Surgical Oncology, (2019), 26, 11, (3510-3516), 10.1245/s10434-019-07577-4)

Michael D. Alvarado, Elizabeth A. Mittendorf, Mediget Teshome, Alastair M. Thompson, Richard J. Bold, Mark A. Gittleman, Peter D. Beitsch, Sarah L. Blair, Kaisa Kivilaid, Quentin J. Harmer, Kelly K. Hunt

Research output: Contribution to journalComment/debatepeer-review

Abstract

In the original article the authors’ disclosures were incomplete.

Original languageEnglish (US)
Pages (from-to)979
Number of pages1
JournalAnnals of surgical oncology
Volume27
DOIs
StatePublished - Dec 2020

ASJC Scopus subject areas

  • Surgery
  • Oncology

Fingerprint

Dive into the research topics of 'Correction to: SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast Cancer (Annals of Surgical Oncology, (2019), 26, 11, (3510-3516), 10.1245/s10434-019-07577-4)'. Together they form a unique fingerprint.

Cite this